NDC codes

FDA NDC Directory
Product NDC (as listed)72162-1286Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72162-1286Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72162-1286-172162128601100 TABLET in 1 BOTTLE, PLASTIC (72162-1286-1)Marketed from Feb 1, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Dexmethylphenidate Hydrochloride
Generic name (nonproprietary)
dexmethylphenidate hydrochloride
Active ingredients
Dexmethylphenidate hydrochloride — 10 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 207901
Marketing start
Listing expires
DEA schedule
CII
Other FDA classes
Central Nervous System Stimulation (Physiologic effect)
Identifiers
Product ID 72162-1286_5dea27aa-7140-44c3-a81f-8edce5854412SPL ID 5dea27aa-7140-44c3-a81f-8edce5854412SPL set ID f65759db-5294-4e82-bb3c-3ea368edaca7RxCUI 899548UNII 1678OK0E08

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162128601 followed by a unit qualifier and the quantity

Package 72162-1286-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Dexmethylphenidate hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 )] . Dexmethylphenidate hydrochloride tablets are a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207901

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207901
ProductStrengthForm · routeLabelerProduct NDC
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 2.5 mg/1TabletOralBryant Ranch Prepack72162-1284
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 5 mg/1TabletOralBryant Ranch Prepack72162-1285
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 5 mg/1TabletOralBryant Ranch Prepack63629-2306
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 2.5 mg/1TabletOralBryant Ranch Prepack63629-2305
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 10 mg/1TabletOralBryant Ranch Prepack63629-2307
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 2.5 mg/1TabletOralCranbury Pharmaceuticals, LLC27808-091
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 5 mg/1TabletOralCranbury Pharmaceuticals, LLC27808-092
Dexmethylphenidate HydrochlorideDexmethylphenidate hydrochloride 10 mg/1TabletOralCranbury Pharmaceuticals, LLC27808-093

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in